BillHR 9169 · 119

PKD Cures Act

Introduced

Jun 4, 2026

Cosponsors

Traction

Last Action

Jun 4, 2026

Bill Summary

Funds research to find a cure for Polycystic Kidney Disease (PKD), a genetic disorder. Requires the National Institutes of Health (NIH) to coordinate this research effort.

Bill Journey

Jun 4, 2026
Jun 4, 2026You Are Here
The committee will review the bill, debate amendments, and vote on whether to advance it to the full chamber.
TBD
The full chamber debates the bill, may amend it, and votes on whether to pass it.
TBD
If passed by the first chamber, the other chamber considers, may amend, and votes on the bill.
TBD
If passed by both chambers, the bill goes to the President to sign into law or veto.

Why It Matters

This bill affects people with PKD, a genetic disorder that can cause kidney failure, and their families, by potentially leading to the development of more effective treatments or a cure. It also impacts researchers and medical professionals working on PKD by providing them with funding and resources to advance their work.

Impact Areas

Sample

Addresses Supply

Targets an underlying shortage driving costs.

Supports Families

Aimed at easing pressure on working households.

Long-term Impact

Effects compound across multiple budget cycles.

Expands Access

Lowers barriers for first-time participants.

Support & Opposition

Sponsor & cosponsor support by party

Democratic1

Cross-party cosponsors0 · 0%

Documents

Full Bill Text
H.R. 9169 · congress.gov

Full text opens on congress.gov, the official source.

Bill Details

Bill TypeHouse Bill · Federal

Primary Topic—

CommitteeCommittee on Energy and Commerce

IntroducedJun 4, 2026

Last UpdatedJun 4, 2026

Latest ActionReferred to the House Committee on Energy and Commerce.

Summary and impact analysis written by Judy (KnowGov's enrichment AI). Bill metadata, status, sponsor, and any floor votes from Prism. Sections marked “Sample” are placeholders not yet connected to live data.